Disease Control

U.S. development agency to lead president's malaria initiative

Published in Medical Letter on the CDC and FDA, January 22nd, 2006

The U.S. Agency for International Development (USAID) is the lead U.S. government agency for implementation of the president's malaria initiative (PMI), a $1.2 billion, 5-year commitment created to dramatically reduce malaria in Africa.

This initiative will be focused, results-based, and will exhibit a high level of financial and programmatic accountability.

While the malaria initiative increases over the next 5 years, USAID's other malaria programs have now been restructured to function in the same, results-based and accountable fashion as the PMI. The changes will effectively combine all USAID malaria activities into a single, strategic...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2006-01-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry